Aura Biosciences, Inc. (AURA) vs Indaptus Therapeutics, Inc. (INDP)

Aura Biosciences, Inc. and Indaptus Therapeutics, Inc. are both Biotechnology companies. Aura Biosciences, Inc. and Indaptus Therapeutics, Inc. are of similar size ($637.8M and $606.8M). Across the 8 metrics below, Aura Biosciences, Inc. leads on 4 and Indaptus Therapeutics, Inc. on 4.

Valuation

Metric AURA INDP Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.81 38.60 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (29.17%) (167.34%) (28.84%)
Free cash flow yield (18.16%) (3.35%) (23.03%)

Profitability

Metric AURA INDP Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (53.49%) (318.04%) (57.72%)
Return on assets (47.42%) (163.84%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AURA INDP Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (0.57%) 52.15% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AURA INDP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.82 19.48 4.73
Net debt to EBITDA 1.29 0.43 0.96

Dividend

Metric AURA INDP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AURA INDP Biotechnology median
Market cap 637.78m 606.77m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack